Article
PSEN2 Thr421Met Mutation in a Patient with Early Onset Alzheimer's Disease.
International journal of molecular sciences - 1 Nov 2022
Yang YoungSoon, Bagyinszky Eva, An Seong Soo A, Kim SangYun
Abstract excerpt
Presenilin-2 (PSEN2) mutation Thr421Met was identified from a 57-years old patient with early onset Alzheimer's disease (EOAD) for the first time in Korea. Previously, this mutation was discovered in an EOAD patient in Japan without a change on amyloid production from the cellular study. Both Korean and Japanese patients developed the disease in their 50s. Memory loss was prominent in both cases, but no...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
